SCHEMBL4009345

SCHEMBL4009345

Cc1cccc([C@](C)(Cc2ccc(Cl)cc2)c2ncc[nH]2)c1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.40
TAAR1 Q96RJ0 4/20 0.35
SLC6A2 P23975 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
HRH1 P35367 1/20 0.34
HTR2B P41595 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ACP3 P15309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4012156 0.88 TAAR1 (0.34) CYP19A1TAAR1MAPTHTT
SCHEMBL1573354 0.72 TAAR1 (0.40) CYP19A1TAAR1SMN1; SMN2
SCHEMBL699180 0.70 CYP19A1 (0.47) CYP19A1TAAR1SMN1; SMN2
SCHEMBL697069 0.69 TAAR1 (0.40) CYP19A1TAAR1SMN1; SMN2
SCHEMBL10549037 0.67 TAAR1 (0.50) TAAR1MAPTSMN1; SMN2
SCHEMBL698787 0.65 CYP19A1 (0.43) CYP19A1TAAR1LMNASMN1; SMN2
SCHEMBL696368 0.65 TAAR1 (0.42) CYP19A1TAAR1SMN1; SMN2
SCHEMBL10601006 0.65 SLC6A2 (0.40) TAAR1SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL706070 0.64 CYP19A1 (0.48) CYP19A1TAAR1CYP1A2CYP3A4CYP2D6
SCHEMBL697724 0.63 TAAR1 (0.46) CYP19A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885TAAR1 2147/4885SLC6A2 364/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885TAAR1 2147/4885SLC6A2 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.